Mortality and Thromboembolic Events in Hypercoagulable States from Rotational Thromboelastography (ROTEM) in Patients Who Undergo Coronary Bypass Surgery
{"title":"Mortality and Thromboembolic Events in Hypercoagulable States from Rotational Thromboelastography (ROTEM) in Patients Who Undergo Coronary Bypass Surgery","authors":"S. Laohathai, P. Samankatiwat","doi":"10.4236/wjcs.2019.910015","DOIUrl":null,"url":null,"abstract":"Purpose: This study is to identify the prevalence of preoperative hypercoagulability \nin Thailand high-risk population assessed by Rotational thromboelastography (ROTEM) and \ntest hypothesis that the pre-surgical ROTEM statuses are related to MACCE \nat 1, 12, 60 months after coronary bypass graft surgery (CABG). Method: This is a prospective \ncohort in consecutive patients who underwent on-pump CABG between 2013-2015. \nBlood samplings were collected and analyzed using ROTEM preoperatively. Hypercoagulable \nstate was defined as any clotting time (CT) or clot formation time (CFT) \nbelow the lower normal limit or amplitude 10 min after CT (A10), Maximum clot \nfirmness (MCF) in ROTEM measurement is above the upper normal limit of EXTEM, INTEM and \nFIBTEM. Results: 43% of CABG patients who \nwere diagnosed as hypercoagulability state assessed by ROTEM. Mortality rate was \nslightly higher in hypercoagulable patients without statistical significance \n(9% vs 5.1%; P = 0.461). However, overall combined uneventful rate was significantly increased in \nhypercoagulable patients in 5 years follow-up (27.2% vs 8.6%; P = 0.012). In \nunivariate analysis, ROTEM hypercoagulability is associated major adverse \ncardiovascular and cerebral event (MACCE) in 5-years follow up [OR (95% CI) = \n3.975 (1.28 - 12.32); P = 0.017]. Conclusion: Hypercoagulable patients \nwere identified 43 percent of patients associated with combine uneventful in 5 \nyears follow-up. ROTEM could be applied as a useful tool in the prediction of outcome \nafter CABG surgery.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Cardiovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/wjcs.2019.910015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study is to identify the prevalence of preoperative hypercoagulability
in Thailand high-risk population assessed by Rotational thromboelastography (ROTEM) and
test hypothesis that the pre-surgical ROTEM statuses are related to MACCE
at 1, 12, 60 months after coronary bypass graft surgery (CABG). Method: This is a prospective
cohort in consecutive patients who underwent on-pump CABG between 2013-2015.
Blood samplings were collected and analyzed using ROTEM preoperatively. Hypercoagulable
state was defined as any clotting time (CT) or clot formation time (CFT)
below the lower normal limit or amplitude 10 min after CT (A10), Maximum clot
firmness (MCF) in ROTEM measurement is above the upper normal limit of EXTEM, INTEM and
FIBTEM. Results: 43% of CABG patients who
were diagnosed as hypercoagulability state assessed by ROTEM. Mortality rate was
slightly higher in hypercoagulable patients without statistical significance
(9% vs 5.1%; P = 0.461). However, overall combined uneventful rate was significantly increased in
hypercoagulable patients in 5 years follow-up (27.2% vs 8.6%; P = 0.012). In
univariate analysis, ROTEM hypercoagulability is associated major adverse
cardiovascular and cerebral event (MACCE) in 5-years follow up [OR (95% CI) =
3.975 (1.28 - 12.32); P = 0.017]. Conclusion: Hypercoagulable patients
were identified 43 percent of patients associated with combine uneventful in 5
years follow-up. ROTEM could be applied as a useful tool in the prediction of outcome
after CABG surgery.